COVID-19 associated Multisystem Inflammatory Syndrome in Children (MIS-C) guidelines; revisiting the Western New York approach as the pandemic evolves.
作者:
关键词
AP, approvedASO, anti-streptolysin OBNP, brain-natriuretic peptideCDC, Center for Disease ControlCOVID-19COVID-19, coronavirus disease 2019CRP, C-reactive proteinCXCL10, C-X-C-motif chemokine ligand 10DCBLD2, Discoidin, CUB and LCCL domain-containing protein 2E, envelope proteinE.U., European UnionECMO, extracorporeal membrane oxygenationEKG, electrocardiogramEM, emergency useFDA, US Food and Drug AuthorityFeverGI, gastrointestinalIL, interleukinIVIG, intravenous immunoglobulin GInflammationKD, Kawasaki diseaseLDH, lactate dehydrogenaseLFTs, liver function testsM, membrane proteinMIS-CMIS-C, Multisystem Inflammatory Syndrome in ChildrenMpred, methylprednisoloneNP, NucleoproteinPCR, polymerase chain reactionPT, prothrombin timePTT, partial thromboplastin timePediatricRBD, receptor binding domainSARS-CoV-2TE, thromboembolic eventsTNF, tumor necrosis factorTWEAK, TNF-like weak inducer of apoptosisU.S., United States of AmericaVA, veno-arterialVLPs, virus-like particlesVTE, venous thromboembolic events
DOI
10.1016/j.ppedcard.2021.101407
PMID
34121829
发布时间
2024-09-08
- 浏览5
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文